 BioSig Technologies, Inc. NASDAQ:BSGM CEO Kenneth Londoner said the company has made great strides on multiple fronts as it accelerates commercial momentum for developing a national installed base of its PURE Precise Uninterrupted Real-time evaluation of Electrograms EP systems. In a letter to shareholders, the company reported recent highlights including that the PURE EP system has now completed over 2,200 patient cases with 75 physicians at 17 hospitals across the United States, the strengthening of its management team, and the launch of its NOVA-5 software which offers greater customization and smarter workflows with the aim of further driving clinical adoption. 